Guardant Health

Redwood City, CA · Founded 2011 · Biotech · Public

Liquid biopsy tests that detect circulating tumor DNA in blood samples for cancer diagnosis, monitoring, and treatment selection

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · guardanthealth.com

Sector
Biotech
Headquarters
Redwood City, CA
Founded
2011
Latest Form D
$320M, Aug 2017
Total capital
$500M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$500M
5 Form D · last Aug 2017
111 months since last filing
Federal contracts
$14K
2 awards · Veterans Affairs, Health and Human S
Rank in Biotech#376 of 4373
Granted patents
16
24 pending · first 2026
Rank in peer group#1 of 342

Capital timeline

20142015201620172018201920202021FEDERAL ↑EQUITY ↓Cumulative $500M$14K4th Form D$82.8M5th Form D$320M
2014201620182020FEDERAL ↑EQUITY ↓Cumulative $500M$14K5th Form D$320M

Latest events

  • Federal contractHealth and Human S · Laboratory Testing$14K
  • Private capital raisedForm D · SEC · 5th filing$320M
  • Private capital raisedForm D · SEC · 4th filing$82.8M
  • Private capital raisedForm D · SEC · 3rd filing$56M
  • Private capital raisedForm D · SEC · 2nd filing$31.5M
  • Private capital raisedForm D · SEC · 1st filing$9.2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 342 peers

Line = median

Biotech · Platform

  • Granted patents#1 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Aaref HilalyDirectorNamed in SEC Form D filings
  • AmirAli TalasazExecutive Officer, DirectorNamed in SEC Form D filings
  • Helmy EltoukhyExecutive Officer, DirectorNamed in SEC Form D filings
  • Michael WileyExecutive OfficerNamed in SEC Form D filings
  • Samir KaulDirectorNamed in SEC Form D filings
  • Samir KaurDirectorNamed in SEC Form D filings
Show all 7 people
  • Warren HogarthDirectorNamed in SEC Form D filings

What it has protected

USPTO · 16 granted of 40
Show all 40 patent records

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .